Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
EDMONTON, Alberta, June 13, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
EDMONTON, Alberta, June 05, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
Positive results obtained from a unique research protocol and surgical methodologyPotential for development of a first-in-class slow-release formulationResults enable Ceapro’s transition to...
-
EDMONTON, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
EDMONTON, Alberta, May 17, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
– Ceapro receives issued European Patent for PGX Technology – – Poster presentation on a new PGX-dried chemical complex gum Arabic/CoQ10 – EDMONTON, Alberta, April 25, 2018 (GLOBE NEWSWIRE) --...
-
- Company well poised to transition to its next phase of growth for expansion into the profitable nutraceutical sector over the next 12 months - - Data expected from the bioavailability study of...
-
EDMONTON, Alberta, April 20, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
EDMONTON, ALBERTA, April 18, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for...
-
EDMONTON, Alberta, April 13, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...